retatrutide phase 2 diabetes trial III study demonstrates 30% weight loss GLP-1 Drugs: FDA Removes Special-Gluten-Free Choose Your Dog's Size:Small Dog (<25 lbs)

retatrutide phase 2 diabetes trial III study demonstrates 30% weight loss GLP-1 Drugs: FDA Removes Special-Gluten-Free Choose Your Dog's Size:Small Dog (<25 lbs)

GLP-1 Drugs: FDA Removes Semaglutide from the Drug Shortage List | Foley & Lardner

Resistant starch can not be digested and acts like a fiber

Special-Gluten-Free

Choose Your Dog's Size:Small Dog (<25 lbs)

metformin: 2000 mg/day Synjardy Extended-Release: For Patients Already on Metformin: -Initial dose: Switch to empagliflozin 10 mg plus similar total daily dose of metformin orally once a day For Patients Already on Empagliflozin: -Initial dose: Switch to empagliflozin at the same total daily dose plus metformin 1000 mg/day orally once a day Patients Already on Synjardy: -Initial dose: Switch to same total daily dose of each component (or nearest appropriate dose of metformin) orally once a day Maintenance: Adjust dose based on efficacy and tolerability